Welcome to our dedicated page for Chemed news (Ticker: CHE), a resource for investors and traders seeking the latest updates and insights on Chemed stock.
Chemed Corporation reports developments across two wholly owned subsidiaries: VITAS Healthcare, a provider of hospice and palliative end-of-life care, and Roto-Rooter, which provides plumbing, drain cleaning, water restoration and related services to residential and commercial customers.
Company news commonly covers quarterly operating results, VITAS patient revenue, admissions and census measures, Roto-Rooter service demand, franchise territory acquisitions, credit facility updates, share repurchases, new hospice-care locations and investor conference presentations.
Chemed Corporation (NYSE:CHE) will present at the RBC Capital Markets Global Healthcare Conference on May 18, 2022, at 8:00 a.m. (ET) in New York City. Investors can access the live audio webcast on the company's website, with a replay available for 90 days post-event. Headquartered in Cincinnati, Ohio, Chemed operates two subsidiaries: VITAS Healthcare, a leading provider of hospice care, and Roto-Rooter, the top plumbing service in the U.S.
Investors should note the presence of forward-looking statements in the communications.
Chemed Corporation (NYSE:CHE) will present at the Bank of America Merrill Lynch 2022 Health Care Conference on May 10, 2022, at 9:20 AM PDT in Las Vegas. The presentation will be available via live webcast, which can be accessed on their website. A replay will be offered within 24 hours for 90 days. Chemed operates two main subsidiaries: VITAS Healthcare, the largest provider of end-of-life hospice care, and Roto-Rooter, a leading plumbing service.
Chemed Corporation (NYSE: CHE) reported Q1 2022 financial results, revealing a 0.6% revenue increase to $531 million. GAAP Diluted EPS rose 5.2% to $4.22, while Adjusted Diluted EPS increased 7.9% to $4.79. However, VITAS Healthcare's revenue declined 5.3% to $299 million, with significant drops in admissions and patient revenue. Conversely, Roto-Rooter experienced a 9.4% revenue growth to $231 million, contributing positively to overall performance. Chemed also repurchased shares valued at $27.4 million.
Chemed Corporation (NYSE: CHE) is set to release its financial results for Q1 2022 on April 26, 2022, after market close. A conference call will follow on April 27, 2022, at 10 a.m. ET to discuss the results and provide business updates. U.S. participants can dial 844-743-2500, while international participants can use +1 661-378-9533. Replay access will be available for one week post-call. Chemed operates VITAS Healthcare and Roto-Rooter, leading in hospice and plumbing services, respectively.
Chemed Corporation (NYSE:CHE) will present virtually at the Oppenheimer 32nd Annual Healthcare Conference on March 16, 2022, at 8:40 a.m. (ET). The presentation will be available via live webcast on the company's website, and a replay will be accessible within 24 hours for 90 days. Chemed operates VITAS Healthcare, the largest hospice care provider, and Roto-Rooter, the leading plumbing services provider in the U.S. Investors are reminded that statements made during the conference may include forward-looking information subject to risks.
Chemed Corporation (CHE) reported fourth-quarter 2021 financial results, highlighting a 1.4% revenue increase to $541 million. GAAP diluted EPS stood at $4.81, with adjusted diluted EPS rising 2.3% to $5.25. VITAS segment experienced a 4.8% revenue decline to $316 million, with a notable drop in admissions of 9.5%. In contrast, Roto-Rooter achieved an 11.8% revenue increase to $225 million and adjusted EBITDA grew 14.2%. The company anticipates a 1.5% to 2.5% revenue decline for VITAS in 2022, while Roto-Rooter projects 8% to 9.5% growth.
Chemed Corporation (NYSE:CHE) has announced a quarterly cash dividend of 36-cents per share, payable on March 18, 2022. Shareholders of record as of February 28, 2022 will receive this dividend, which matches the amount paid in December 2021. This marks the 203rd consecutive quarterly dividend in Chemed's 50-year history as a public company, reflecting the company's commitment to returning value to shareholders.
Chemed Corporation (NYSE:CHE) will release its fourth quarter financial results for the period ending December 31, 2021, on February 24, 2022, after market close. A conference call to discuss these results is scheduled for February 25, 2022, at 10 a.m. ET, accessible via phone and webcast. Chemed operates VITAS Healthcare, the largest hospice provider, and Roto-Rooter, a leading plumbing service. Forward-looking statements regarding the company's performance highlight inherent risks that could lead to actual results differing materially from projections.
Chemed Corporation (NYSE:CHE) will present at the BofA Securities 2021 Virtual Home Care Conference on December 7, 2021, at 11:00 AM (ET). The presentation will be available via live webcast on the Chemed website, with a replay accessible within 24 hours for 90 days. Headquartered in Cincinnati, Ohio, Chemed operates subsidiaries VITAS Healthcare, the largest end-of-life hospice care provider, and Roto-Rooter, the leading plumbing and drain cleaning service in the U.S.
Chemed Corporation (NYSE:CHE) has authorized an additional $300 million for stock repurchase under its existing program, funded by operational cash and a revolving credit facility. This move aims to enhance shareholder value by reducing the number of outstanding shares, potentially leading to an increase in earnings per share (EPS). Chemed is known for its subsidiaries VITAS Healthcare, the largest hospice care provider, and Roto-Rooter, a leading plumbing service.